V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody

Product Graph
312€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx421022
tested applications
FCM

Description

V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody is a Human Monoclonal antibody for the detection of V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) in Human samples.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1)
Host
Human
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1 Kappa
Clone ID
O308
Purity
> 95%
Purification
Purified by Protein A/G affinity chromatography.
Size 1
50 µg
Size 2
100 µg
Form
Liquid
Tested Applications
FCM
Buffer
0.01 M PBS, pH 7.4.
Availability
Shipped within 5-12 working days.
Storage
Store at 4 °C if the entire vial will be used within 1 week. Aliquot and store at -20 °C or -80 °C for long-term storage. Avoid repeated freeze-thaw cycles.
Dry Ice
No
UniProt ID
Q7Z7D3
Gene ID
79679
NCBI Accession
NP_001240778.1
Background
Antibody anti-VTCN1
Status
RUO
Note
Concentration: 1 mg/ml -

Descripción

Related Products

EH1214

Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit

Ver Producto
FNab09461

VTCN1 antibody

Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.

Ver Producto
P1973

Recombinant Human VTCN1

Ver Producto